Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18536675 | 0.84 | — | — | |
| Water SCHEMBL11637323 | 0.76 | — | — | |
| SCHEMBL6837156 | 0.73 | MIF (0.35) | — | |
| SCHEMBL133474 | 0.73 | GSK3A (0.39) | MEN1KMT2A | |
| SCHEMBL1695372 | 0.72 | MAPT (0.36) | MEN1KMT2A | |
| SCHEMBL18536621 | 0.70 | MEN1 (0.30) | MEN1KMT2A | |
| SCHEMBL9131326 | 0.69 | F2 (0.52) | — | |
| SCHEMBL6836947 | 0.68 | — | — | |
| SCHEMBL530530 | 0.67 | CASP3 (0.40) | MEN1KMT2A | |
| SCHEMBL2601688 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4622991-A2 | SYNTHESIS OF A CYCLIC PEPTIDE | Janssen Pharmaceutica NV (BE) | 2025-10-01 | — | — | EP | claimed |
| US-20250276995-A1 | PRODUCTION METHOD FOR PEPTIDE COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-04 | — | — | US | claimed |
| EP-4488283-A1 | PRODUCTION METHOD FOR PEPTIDE COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-01-08 | — | — | EP | claimed |
| CN-118715234-A | Process for producing peptide compound | 中外制药株式会社 | 2024-09-27 | — | — | CN | claimed |
| WO-2024110477-A2 | SYNTHESIS OF A CYCLIC PEPTIDE | JANSSEN PHARMACEUTICA NV (BE) | 2024-05-30 | — | — | WO | claimed |
| EP-4201951-B1 | METHOD FOR PEPTIDE SYNTHESIS | BACHEM HOLDING AG (CH) | 2023-11-22 | — | — | EP | claimed |
| WO-2023195516-A1 | PRODUCTION METHOD FOR PEPTIDE COMPOUND | 中外製薬株式会社 | 2023-10-12 | — | — | WO | claimed |
| WO-2023117904-A1 | METHOD FOR PEPTIDE SYNTHESIS | BACHEM HOLDING AG (CH) | 2023-06-29 | — | — | WO | claimed |
| EP-4201951-A1 | METHOD FOR PEPTIDE SYNTHESIS | Bachem Holding AG (CH) | 2023-06-28 | — | — | EP | claimed |
| EP-2588665-B1 | BLEACHING OF PULP | NOVOZYMES AS (DK) | 2019-05-08 | — | — | EP | claimed |
| US-9670614-B2 | Color modification of textile | NOVOZYMES A/S (DK) | 2017-06-06 | — | — | US | claimed |
| US-9222078-B2 | Bleaching of pulp | NOVOZYMES A/S (DK) | 2015-12-29 | — | — | US | claimed |
| US-20140310887-A1 | COLOR MODIFICATION OF TEXTILE | NOVOZYMES A/S (DK) | 2014-10-23 | — | — | US | claimed |
| US-20130098570-A1 | BLEACHING OF PULP | NOVOZYMES A/S (DK) | 2013-04-25 | — | — | US | claimed |
| EP-0882814-B1 | System and process for the electrochemical cleavage of compounds | CONSORTIUM ELEKTROCHEM IND (DE) | 2002-10-23 | — | — | EP | claimed |
| US-6187170-B1 | SYSTEM FOR THE ELECTROCHEMICAL CLEAVAGE OF COMPOUNDS WHICH INCLUDES A MEDIATOR AND AT LEAST TWO ELECTRODES FOR THE ELECTROCHEMICAL ACTIVATION OF THE MEDIATOR | Consortium für elektrochemische Industrie GmbH (DE) | 2001-02-13 | — | — | US | claimed |
| JP-11012972-A | — | — | None | — | — | JP | disclosed |
| EP-4602064-B1 | METHOD OF MANUFACTURING A PEPTIDE WITH A LYSINE DERIVATIVE | BACHEM HOLDING AG (CH) | 2026-05-13 | — | — | EP | disclosed |
| US-5292759-A | O-benzyloxime ethers and crop protection agents containing these compounds | BASF AKTIENGESELLSCHAFT (DE) | 1994-03-08 | — | — | US | disclosed |
| US-5194662-A | Insecticides, fungicides for plants | BASF AKTIENGESELLSCHAFT (DE) | 1993-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250276995-A1 | PRODUCTION METHOD FOR PEPTIDE COMPOUND | VIP, IAPP, QPCT | MEN1 340/4885KMT2A 2337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.